Abstract
A new and efficient method for the synthesis of hexahydropyrimidine-fused 1,4-naphthoquinones in one step with high yields from the reaction of lawsone with 1,3,5-triazinanes was developed.
Keywords: hydrobenzo[g]quinazoline; microwave; naphthoquinone; 1,3-quinazoline; 1,3,5-triazinane
Introduction
Quinones represent a diverse family of naturally occurring secondary metabolites [1–3]. Interest in these substances has intensified in recent years due to their pharmacological importance [4]. Heterocycle-fused naphthoquinones (Figure 1) such as naphtho[2,3-b]furan [5–14], naphtho-pyran [15–18], benzo[f]indole [19–24], benzo[g]quinolone [25], benzo[b]carbazole [26], naphtho[2,3-b]thiophene [27–33] and naphtho[2,3-b]]oxazole [34] have been demonstrated to display various biological activities. There are several specific and general methods reported in the literature that describe the preparation and biological activity of heterocycle-fused naphthoquinone compounds [35]. Recently, Iida et al. described a general method for the construction of pyrrole-, furan- and thiophene-fused naphthoquinones [36].
Figure 1.
General template for heterocycle-fused 1,4-naphthoquinones.
For several years, our group has been interested in developing new synthetic methods for the preparation of heterocycle-fused 1,4-naphthoquinones or heterocycle-tethered 1,4-naphthoquinones. 1,3-Quinazolines are nitrogenated heterocycles that are present in several products. However, there are only three procedures for the preparation of hexahydropyrimidine-fused 1,4-naphthoquinones available. Some of them are restrictive, troublesome and produce the hexahydropyrimidine-1,4-naphthoquinones in low yields. Möhrle and Herbruggen synthesized unsymmetrical hexahydropyrimidine-fused 1,2- and 1,4-naphthoquinones by the reaction of 4-amino-l,2-naphthoquinone and 2-amino-1,4-naphthoquinone with amines and formaldehyde in moderate yields [37]. Ohta et al. studied the nucleophilic addition reaction of methylamine to 2-bromo-3-hydroxymethyl-1,4-naphthoquinone (1) and obtained hexahydropyrimidine-fused 1,4-naphthoquinone (5) as side product (Scheme 1) [38–39]. This reaction was non-selective and formed a mixture of four products (2–5) that are derived from the addition of methylamine to both of the electrophilic sites of the starting material 1. In the same publication, the authors reported another method that was more selective, which involved the addition of two equivalents of a monoalkyl amine (R-NH2) to menadione (6) to give hexahydropyrimidine-fused 1,4-naphthoquinones 5, 11–13 in low yields.
Scheme 1.
Methods for the preparation of hexahydropyrimidine-fused 1,4-naphthoquinones.
Results and Discussion
Herein we describe a new method for the synthesis of hexahydropyrimidine-fused 1,4-naphthoquinones (13 and 21–25) in high yields, from the sequential reaction of readily available 1,3,5-triazinanes 14–19 with 2-hydroxy-1,4-naphthoquinone (20, or lawsone) under microwave irradiation (Scheme 2).
Scheme 2.
Synthesis of hexahydropyrimidine-fused 1,4-naphthoquinones 13 and 21–25.
The 1,3,5-triazinanes have several synthetic and biological applications [40]. These substances are easily prepared from commercially available amines and formaldehyde in toluene in yields ranging from 75–90%. Barluenga and coworkers [41] have previously shown that 1,3,5-triazinanes undergo fragmentation at elevated temperatures to form 3 equivalents of alkyl- or aryl-formimines in situ. The latter compounds may serve as electrophilic agents for aminoalkylation reactions. Our research group also investigated the aminoalkylation of 2-amino-1,4-naphthoquinone with formaldehyde under microwave irradiation to produce two series of N,O-acetals and N,S-acetals. These compounds were obtained in good yields, and several of them showed promising antibacterial activity [42].
The structures of the synthesized 1,3,5-triazinanes were confirmed by spectroscopic techniques such as NMR, 1H and 13C-APT, infrared spectroscopy (FTIR) and high resolution mass spectrometry. The synthesis of compounds 14 [43] and 17 [44] has been previously reported in the literature. The structure of compound 18 was confirmed by X-ray diffraction analysis and Figure 2 shows the ORTEP diagram of this compound. The details of the crystal data and refinements are collected in Supporting Information File 1, Table S1.
Figure 2.
ORTEP diagram of compound 18 depicted with ellipsoids drawn at the 50% probability level and the atom-numbering scheme.
The crystal structure of compound 18 contains two molecules per asymmetric unit. Two factors explain the differences between molecules A and B (Figure 2): (1) different intermolecular interactions and (2) small differences in the torsion angles of the p-substituted benzyl groups. The 1,3,5-triazinane rings of 18 (molecules A and B) adopt a chair conformation, with Cremer–Pople puckering parameters q2 and Φ2 of 0.023(9) Å and 323.0(20)º, respectively, for molecule A, and q2 and Φ2 of 0.016(3) Å and 2.0(25)º, respectively, for molecule B.
Next the reaction between 1,3,5-triazinanes 14–19 and 2-hydroxy-1,4-naphthoquinone (20) was developed to prepare fused hexahydropyrimidine-1,4-naphthoquinones 13 and 21–25 using in situ generated alkyl formimines. Performing the reaction without heating proceeds very slow and after 24 hours extensive degradation products were observed. By elevating the temperature and or changing the solvent some product is formed but the yields were very low. On the other hand, when the reactions were conducted in an equimolar ratio under microwave irradiation (300 Monowave model brand Aanton Paar) in chloroform for 15 minutes at a temperature of 150 °C, the desired products were obtained in good yields (75–80%, Scheme 2). All structures of the benzo-fused tetrahydroquinazolines were characterized by 1H NMR and 13C-APT, infrared spectroscopy (FTIR) and high resolution mass spectrometry. Using compound 23 as an example, it can be observed that its 1H NMR spectrum contains a doublet of doublets (J = 0.98 and 7.8 Hz) at 7.98 ppm attributed to the hydrogen H-5 of the naphthoquinone moiety, a multiplet at 7.16–7.25 ppm related to the aromatic protons on the phenyl ring (H-3”’–H, 7”’), and four singulets corresponding to the H1’ (C–CH2–N), H1” (N–CH2–N), H-1”’ (N–CH2–Ph) and H-1”” (N–CH2–Ph) methylene protons at 3.60 ppm, 3.77 ppm, 3.84 ppm and 4.75 ppm, respectively. The high resolution mass spectrum of compound 23 showed a molecular ion [M + H]+ at m/z 395.2062, which corresponds with the calculated mass for C26H22N2O2H [M + H]+ of 395.1715. The structure of compound 23 was further elucidated by X-ray diffraction analysis (Figure 3). It confirmed the insertion of two imines to form a hexahydropyrimidine ring which is coupled to a 1,4-naphthoquinone moiety. Figure 3 shows the ORTEP diagram of compound 23 and the details of the crystal data and refinements are given in Supporting Information File 1, Table S2.
Figure 3.
ORTEP diagram of compound 23 depicted with ellipsoids drawn at the 50% probability level and the atom-numbering scheme.
In the crystal structure, the six-membered nitrogen-containing ring of 23 adopts a half boat conformation (Cremer–Pople puckering parameters [45] q2 and Φ2 of 0.374(9) Å and 119.0(1)) in which the N(3) atom is located at 0.641(2) Å out of the plane of the other five atoms C(2), N(1), C(4a), C(10) and C(4).
A possible mechanism that could explain the formation of the tetrahydrobenzo[g]quinazolines 13 and 21–25 is shown in Scheme 3. It initially involves the in situ formation of three thermally generated iminium ions or the equivalent methylformimines from the corresponding triazinane which then react with lawsone (20) at its two nucleophilic sites, thus forming products (Scheme 3).
Scheme 3.
Proposed mechanism for the formation of 13 and 21–25.
Conclusion
A new method for the synthesis of new heterocyclic hexahydropyrimidines fused to a 1,4-naphthoquinone system (13 and 21–25) was developed. The products were obtained in one step, under microwave irradiation and with excellent yields. This method is a more efficient alternative for the preparation of benzo-fused tetrahydroquinazolindiones than the method described in the literature. The structures of all starting 1,3,5-triazinanes and products were confirmed by spectroscopical methods and X-ray diffraction analysis.
Supporting Information
Experimental procedures and spectral data.
Acknowledgments
The authors thank the CAPES, CNPq and FAPERJ for funding this research project. The authors also thank LaReMN/UFF and LARE-DRX/UFF (FAPERJ) for the NMR and X-ray data.
References
- 1.Patai S. The chemistry of the quinoid compounds. London, England: John Wiley & Sons; 1974. [Google Scholar]
- 2.Patai S, Rappoport Z. The Chemistry of the Functional Groups. The Chemistry of the Quinonoid Compounds. New York, USA: John Wiley & Sons; 1988. [Google Scholar]
- 3.Thomson R H. Naturally Occurring Quinones IV. London, England: Blackie Academic & Professional; 1997. [Google Scholar]
- 4.Ferreira V F, da Rocha D R, da Silva F C, Ferreira P G, Boechat N A, Magalhães J L. Expert Opin Ther Pat. 2013;23:319–331. doi: 10.1517/13543776.2013.749862. [DOI] [PubMed] [Google Scholar]
- 5.Rao M M, Kingston D G I. J Nat Prod. 1982;45:600–604. doi: 10.1021/np50023a014. [DOI] [PubMed] [Google Scholar]
- 6.Cardoso M F C, Rodrigues P C, Oliveira M E I M, Gama I L, da Silva I M C B, Santos I O, Rocha D R, Pinho R T, Ferreira V F, de Souza M C B V, et al. Eur J Med Chem. 2014;84:708–717. doi: 10.1016/j.ejmech.2014.07.079. [DOI] [PubMed] [Google Scholar]
- 7.Eyong K O, Kumar P S, Kuete V, Folefoc G N, Nkengfack E A, Baskaran S. Bioorg Med Chem Lett. 2008;18:5387–5390. doi: 10.1016/j.bmcl.2008.09.053. [DOI] [PubMed] [Google Scholar]
- 8.Ferreira M d P S B C, Cardoso M F d C, da Silva F d C, Ferreira V F, Lima E S, Souza J V B. Ann Clin Microbiol Antimicrob. 2014;13:No. 26. doi: 10.1186/1476-0711-13-26. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Teimouri M B, Khavasi H R. Tetrahedron. 2007;63:10269–10275. doi: 10.1016/j.tet.2007.07.082. [DOI] [Google Scholar]
- 10.da Silva A J M, Netto C D, Pacienza-Lima W, Torres-Santos E C, Rossi-Bergmann B, Maurel S, Valentin A, Costa P R R. J Braz Chem Soc. 2009;20:176–182. doi: 10.1590/S0103-50532009000100026. [DOI] [Google Scholar]
- 11.Ueda S, Umemura T, Dohguchi K, Matsuzaki T, Tokuda H, Nishino H, Iwashima A. Phytochemistry. 1994;36:323–325. doi: 10.1016/S0031-9422(00)97069-9. [DOI] [PubMed] [Google Scholar]
- 12.Wu C, Johnson R K, Mattern M R, Wong J C, Kingston D G I. J Nat Prod. 1999;62:963–968. doi: 10.1021/np9900019. [DOI] [PubMed] [Google Scholar]
- 13.Jiménez-Alonso S, Guasch J, Estévez-Braun A, Ratera I, Veciana J, Ravelo A G. J Org Chem. 2011;76:1634–1643. doi: 10.1021/jo102233j. [DOI] [PubMed] [Google Scholar]
- 14.Reichstein A, Vortherms S, Bannwitz S, Tentrop J, Prinz H, Müller K. J Med Chem. 2012;55:7273–7284. doi: 10.1021/jm3009597. [DOI] [PubMed] [Google Scholar]
- 15.Ferreira S B, da Silva F d C, Pinto A C, Gonzaga D T G, Ferreira V F. J Heterocycl Chem. 2009;46:1080–1097. doi: 10.1002/jhet.232. [DOI] [Google Scholar]
- 16.da Costa E C B, Amorim R, da Silva F C, Rocha D R, Papa M P, de Arruda L B, Mohana-Borges R, Ferreira V F, Tanuri A, da Costa L J, et al. PLoS One. 2013;8:e82504. doi: 10.1371/journal.pone.0082504. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.da Rocha D R, de Souza A C G, Resende J A L C, Santos W C, dos Santos E A, Pessoa C, de Moraes M O, Costa-Lotufo L V, Montenegro R C, Ferreira V F. Org Biomol Chem. 2011;9:4315–4322. doi: 10.1039/c1ob05209h. [DOI] [PubMed] [Google Scholar]
- 18.Ferreira V F, Ferreira S B, da Silva F d C. Org Biomol Chem. 2010;8:4793–4802. doi: 10.1039/c0ob00277a. [DOI] [PubMed] [Google Scholar]
- 19.Tseng C-M, Wu Y-L, Chuang C-P. Tetrahedron. 2004;60:12249–12260. doi: 10.1016/j.tet.2004.10.029. [DOI] [Google Scholar]
- 20.Shvartsberg M S, Kolodina E A, Lebedeva N I, Fedenok L G. Tetrahedron Lett. 2009;50:6769–6771. doi: 10.1016/j.tetlet.2009.09.110. [DOI] [Google Scholar]
- 21.Inman M, Moody C J. J Org Chem. 2010;75:6023–6026. doi: 10.1021/jo101071c. [DOI] [PubMed] [Google Scholar]
- 22.Acosta A, de la Cruz P, De Miguel P, Diez-Barra E, de la Hoz A, Langa F, Loupy A, Majdoub M, Martin N, Sanchez C, et al. Tetrahedron Lett. 1995;36:2165–2168. doi: 10.1016/0040-4039(95)00202-N. [DOI] [Google Scholar]
- 23.Oostveen E A, Speckamp W N. Tetrahedron. 1987;43:255–262. doi: 10.1016/S0040-4020(01)89952-X. [DOI] [Google Scholar]
- 24.Comer E, Murphy W S. ARKIVOC. 2003;7:286–296. [Google Scholar]
- 25.Bala B D, Muthusaravanan S, Perumal S. Tetrahedron Lett. 2013;54:3735–3739. doi: 10.1016/j.tetlet.2013.04.125. [DOI] [Google Scholar]
- 26.Inoue A, Nomura Y, Kuroki N, Konishi K. J Synth Org Chem, Jpn. 1958;16:536–540. doi: 10.5059/yukigoseikyokaishi.16.536. [DOI] [Google Scholar]
- 27.Kobayashi K, Yoneda K, Uchida M, Matsuoka H, Morikawa O, Konishi H. Heterocycles. 2001;55:2423–2430. doi: 10.3987/COM-01-9358. [DOI] [Google Scholar]
- 28.Valderrama J A, Astudillo C, Tapia R A, Prina E, Estrabaud E, Mahieux R, Fournet A. Chem Pharm Bull. 2002;50:1215–1218. doi: 10.1248/cpb.50.1215. [DOI] [PubMed] [Google Scholar]
- 29.Tapia R A, Alegria L, Pessoa C D, Salas C, Cortés M J, Valderrama J A, Sarciron M-E, Pautet F, Walchshofer N, Fillion H. Bioorg Med Chem. 2003;11:2175–2182. doi: 10.1016/S0968-0896(03)00122-6. [DOI] [PubMed] [Google Scholar]
- 30.Ryu C-K, Choi I H, Lee J Y, Jung S H. Heterocycles. 2005;65:1205–1214. doi: 10.3987/COM-05-10341. [DOI] [Google Scholar]
- 31.Valderrama J A, Espinoza O, Rodriguez J, Theoduloz C. Lett Org Chem. 2009;6:278–281. doi: 10.2174/157017809788490006. [DOI] [Google Scholar]
- 32.Campiglia P, Aquino C, Bertamino A, De Simone N, Sala M, Castellano S, Santoriello M, Grieco P, Novellino E, Gomez-Monterrey I M. Org Biomol Chem. 2010;8:622–627. doi: 10.1039/b918898c. [DOI] [PubMed] [Google Scholar]
- 33.Gomez-Monterrey I, Campiglia P, Aquino C, Bertamino A, Granata I, Carotenuto A, Brancaccio D, Stiuso P, Scognamiglio I, Rusciano M R, et al. J Med Chem. 2011;54:4077–4091. doi: 10.1021/jm200094h. [DOI] [PubMed] [Google Scholar]
- 34.Hamdan A J, Al-Jaroudi S. Arabian J Sci Eng, Sect A. 2003;28:51. [Google Scholar]
- 35.Sartori M F. Chem Rev. 1963;63:279–296. doi: 10.1021/cr60223a005. [DOI] [Google Scholar]
- 36.Ueda K, Yamashita M, Sakaguchi K, Tokuda H, Iida A. Chem Pharm Bull. 2013;61:648–654. doi: 10.1248/cpb.c13-00102. [DOI] [PubMed] [Google Scholar]
- 37.Möhrle H, Schulte Herbrüggen G. Arch Pharm. 1991;324:165–171. doi: 10.1002/ardp.19913240307. [DOI] [Google Scholar]
- 38.Ohta S, Hinata Y, Yamashita M, Kawasaki I, Jinda Y, Horie S. Chem Pharm Bull. 1994;42:1730–1735. doi: 10.1248/cpb.42.1730. [DOI] [PubMed] [Google Scholar]
- 39.Ohta S, Hinata Y, Yamashita M, Kawasaki I, Shoji T, Yoshikawa H, Obana Y. Chem Pharm Bull. 1994;42:1185–1190. doi: 10.1248/cpb.42.1185. [DOI] [PubMed] [Google Scholar]
- 40.Reis M I P, Romeiro G A, Damasceno R, da Silva F d C, Ferreira V F. Rev Virtual Quim. 2013;5:283–299. doi: 10.5935/1984-6835.20130027. [DOI] [Google Scholar]
- 41.Barluenga M, Bayón A M, Campos P, Asensio G, Gonzalez-Nuñez E, Molina Y. J Chem Soc, Perkin Trans 1. 1988:1631–1636. doi: 10.1039/P19880001631. [DOI] [Google Scholar]
- 42.Jordão A K, Novais J, Leal B, Escobar A C, dos Santos Júnior H M, Castro H C, Ferreira V F. Eur J Med Chem. 2013;63:196–201. doi: 10.1016/j.ejmech.2013.01.010. [DOI] [PubMed] [Google Scholar]
- 43.Guillemin J C, Denis J M. J Chem Soc, Chem Commun. 1985:951–952. doi: 10.1039/C39850000951. [DOI] [Google Scholar]
- 44.Smith G S, Berlin K D, Zisman S A, Holt E M, Green V A, Van Der Helm D. Phosphorus Sulfur Relat Elem. 1988;39:91–111. doi: 10.1080/03086648808072860. [DOI] [Google Scholar]
- 45.Cremer D, Pople J A. J Am Chem Soc. 1975;97:1354–1358. doi: 10.1021/ja00839a011. [DOI] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Experimental procedures and spectral data.